- Home
- BTCT vs TXMD Comparison
BTCT vs TXMD Comparison
Compare BTCT & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTCT
- TXMD
- Stock Information
- Founded
- BTCT 2006
- TXMD 2008
- Country
- BTCT Singapore
- TXMD United States
- Employees
- BTCT N/A
- TXMD N/A
- Industry
- BTCT Other Consumer Services
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- BTCT Real Estate
- TXMD Health Care
- Exchange
- BTCT Nasdaq
- TXMD Nasdaq
- Market Cap
- BTCT 19.8M
- TXMD 17.1M
- IPO Year
- BTCT N/A
- TXMD N/A
- Fundamental
- Price
- BTCT $2.98
- TXMD $1.18
- Analyst Decision
- BTCT
- TXMD
- Analyst Count
- BTCT 0
- TXMD 0
- Target Price
- BTCT N/A
- TXMD N/A
- AVG Volume (30 Days)
- BTCT 132.3K
- TXMD 69.5K
- Earning Date
- BTCT 08-13-2025
- TXMD 08-11-2025
- Dividend Yield
- BTCT N/A
- TXMD N/A
- EPS Growth
- BTCT N/A
- TXMD N/A
- EPS
- BTCT N/A
- TXMD N/A
- Revenue
- BTCT $11,675,000.00
- TXMD $1,841,000.00
- Revenue This Year
- BTCT $13.58
- TXMD $427.09
- Revenue Next Year
- BTCT N/A
- TXMD N/A
- P/E Ratio
- BTCT N/A
- TXMD N/A
- Revenue Growth
- BTCT 28.68
- TXMD 53.55
- 52 Week Low
- BTCT $1.32
- TXMD $0.70
- 52 Week High
- BTCT $26.58
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- BTCT 42.20
- TXMD 47.25
- Support Level
- BTCT $2.75
- TXMD $1.11
- Resistance Level
- BTCT $3.25
- TXMD $1.22
- Average True Range (ATR)
- BTCT 0.21
- TXMD 0.09
- MACD
- BTCT 0.00
- TXMD 0.00
- Stochastic Oscillator
- BTCT 47.30
- TXMD 42.31
About BTCT BTC Digital Ltd.
BTC Digital Ltd is a crypto asset technology company based in the U.S. with a focus on bitcoin mining. The company also generates revenue through mining machine resale and rental business operations. Geographically, the financial assets of the company is located in the United States, Singapore, Hong Kong and the PRC.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.